Thuiswerker schreef op 22 juni 2020 17:22:
Stock Price Forecast
The 4 analysts offering 12-month price forecasts for Onconova Therapeutics Inc have a median target of 1.65, with a high estimate of 2.00 and a low estimate of 1.25. The median estimate represents a +169.48% increase from the last price of 0.61.
Wat denken jullie van onderstaande comments?
no RS
Big data coming on Ph3 trial in few weeks, months
Ph2/3 starting soon
Other partnerships worldwide
Strong product with good potential
$250-350 million milestone payment once approved, this brings us to US$ 2-3 cash.
Sales potential: Over a billion, this would generate 40-50% margin or more, or $400-500 million, another $2-3 dollars in cash, bringing total to US$ 5-6 Cash, 10x multiple would be $50-60, take it easy guys, looking forward to chat in 2-3 years from now.